Target intelligence / Profile preview

RNA, U6 small nuclear 1210, pseudogene (RNU6-1210P)

Target
RNU6-1210P
Molecular classification
Other, Pseudogene, non-coding RNA, small nuclear RNA family, snRNA pseudogene
01

Overview

RNA, U6 small nuclear 1210, pseudogene (RNU6-1210P) is a human genomic locus annotated as a pseudogene related to the U6 small nuclear RNA (snRNA) gene family[1][7]. The functional U6 snRNA is a highly conserved non-coding RNA essential for the spliceosome, the macromolecular machinery responsible for excising introns during pre-mRNA splicing[3][5]. Pseudogenes such as RNU6-1210P are thought to be non-functional genetic elements, likely derivatives of retrotransposition or segmental duplication events, and do not produce active RNA or protein molecules. Their sequences may share homology with parental genes but lack the ability to encode functional products or participate directly in splicing or other cellular processes[1][7]. There is currently no evidence or scientific consensus supporting RNU6-1210P as a therapeutic target, disease biomarker, or drug interaction site. The U6 snRNA gene family is notable in human and other vertebrate genomes for being represented by multiple copies, including functional snRNAs and numerous pseudogenes, further underlining that many annotated loci like RNU6-1210P are evolutionary byproducts and not drug targets or biologically active elements[3][5]. If searching for functional relevance or druggability, focus would be on the canonical U6 snRNA, not its pseudogenes.

Other names
RNU6-1210PU6 snRNA pseudogene 1210RNA, U6 small nuclear 1210, pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 1210, pseudogene (RNU6-1210P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1210, pseudogene (RNU6-1210P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call